Acute mast cell leukemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Jul 2024Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).

Essen Biotech — PHASE1, PHASE2

TrialRECRUITING
Mar 2024Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Kite, A Gilead Company — PHASE2

TrialACTIVE NOT RECRUITING
Aug 2021NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Nkarta, Inc. — PHASE1

TrialACTIVE NOT RECRUITING
Feb 2020Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

University of Michigan Rogel Cancer Center — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Acute mast cell leukemia.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial
1PHASE1, PHASE2
1Total recruiting
Search clinical trials for Acute mast cell leukemia

Recent News & Research

No recent news articles indexed yet for Acute mast cell leukemia.
Search PubMed for Acute mast cell leukemia

Browse all Acute mast cell leukemia news →

Specialist Network

Top 6 by expertise

View all Acute mast cell leukemia specialists →

Quick Actions